Measuring quality of life in ALS/MND: validation of the WHOQOL-BREF.

MLA

Young, Carolyn A., et al. “Measuring Quality of Life in ALS/MND: Validation of the WHOQOL-BREF.” Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, June 2020, pp. 1–9. EBSCOhost, https://doi.org/10.1080/21678421.2020.1752244.

APA

Young, C. A., Mills, R., Al-Chalabi, A., Burke, G., Chandran, S., Dick, D. J., Ealing, J., Hanemann, C. O., Harrower, T., Mcdermott, C. J., Majeed, T., Pinto, A., Talbot, K., Walsh, J., Williams, T. L., & Tennant, A. (2020). Measuring quality of life in ALS/MND: validation of the WHOQOL-BREF. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 1–9. https://doi.org/10.1080/21678421.2020.1752244

Chicago

Young, Carolyn A, Roger Mills, Ammar Al-Chalabi, Georgina Burke, Siddharthan Chandran, David J Dick, John Ealing, et al. 2020. “Measuring Quality of Life in ALS/MND: Validation of the WHOQOL-BREF.” Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, June, 1–9. doi:10.1080/21678421.2020.1752244.